Devyser secures a four-year tender in France for Devyser Compact
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
News | November 27, 2024
Recently we proudly hosted our first Capital Markets Day, welcoming around 50 investors and key stakeholders.
The program featured insights from our executive management team and external speakers, followed by a Q&A session and a unique opportunity to explore our state-of-the-art facilities. This event marked an important step in strengthening our dialogue with the financial community and sharing our vision, strategy, and future opportunities.
To ensure everyone has the chance to see the event, the recording is available here: https://ir.financialhearings.com/devyser-cmd-2024
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
Read More
Devyser is proud to announce that One Lambda Devyser Chimerism and Advyser Chimerism have been...
Read More
Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its...
Read More
Devyser today announced the enrollment of the first patient in its Devyser Accept cfDNA clinical...
Read More